Showing 401-410 of 9351 results for "".
From Training to Transformation: How Leaders Get the Most Out of Educating Their Team
https://practicaldermatology.com/issues/september-2025/from-training-to-transformation-how-leaders-get-the-most-out-of-educating-their-team/37640/Imagine investing thousands of dollars in staff time and tuition for the latest aesthetic techniques or business courses—sending employees to conferences or bringing in an expert for in-office training—only to watch those skills fade, or be underused or forgotten.Mergers and Acquisitions in Derm and Aesthetics: Market Outlook
https://practicaldermatology.com/issues/september-2025/mergers-and-acquisitions-in-derm-and-aesthetics-market-outlook/37631/We took a deeper look into the dermatology and aesthetics mergers and acquisitions (M&A) market in a conversation with two of our team members, Drew Thomas and Jordan Frickle, who are closely involved in this sector. The following discussion brings together their perspectives on current trends,All About Acne in 2017
https://practicaldermatology.com/topics/psoriasis/all-about-acne-in-2017/20777/Dermatologist Linda Stein Gold, MD discusses new directions in acne treatment.Reflecting on 2016: Big Stories in Acne, Psoriasis and AD
https://practicaldermatology.com/topics/psoriasis/reflecting-on-2016-big-stories-in-acne-psoriasis-and-ad/20845/Columnists take stock of advancements over the last 12 months, with a focus on clinical implications.Save Big Bucks by Using Vendor-Sponsored Customer Loyalty Programs
https://practicaldermatology.com/topics/practice-management/save-big-bucks-by-using-vendor-sponsored-customer-loyalty-programs/21223/Vendors invest millions of dollars in sophisticated direct-to-consumer loyalty campaigns designed to drive traffic to the practices they serve. Smart practices use these programs to their advantage to reward, recruit, retain, and convert patients.Melanoma Treatment Landscape Evolves
https://practicaldermatology.com/topics/skin-cancer-photoprotection/melanoma-treatment-landscape-evolves/21314/The first agent to target the PD-1 pathway, pembrolizumab may prolong life expectancy in some patients.An Overview of Topical Acne Therapy
https://practicaldermatology.com/issues/supplements/an-overview-of-topical-acne-therapy/21619/It's important to recall the rationale for topical therapy, its occasional limitations, and its potential to benefit a majority of acne patients.Laser Therapy for Atrophic Acne Scars: A Case and Evidence-based Updates
https://practicaldermatology.com/topics/acne-rosacea/laser-therapy-for-atrophic-acne-scars-a-case-and-evidence-based-updates/23737/Food for Thought: A Closer Look at Diet and Acne
https://practicaldermatology.com/topics/general-topics/food-for-thought-a-closer-look-at-diet-and-acne/21308/Lidocaine Shortage: Perspectives, Alternatives, and Pathways Forward
https://practicaldermatology.com/topics/practice-management/lidocaine-shortage-perspectives-alternatives-and-pathways-forward/23949/Supply chain issues, communication barriers, and regulatory inconsistencies cause problems for practitioners and patients.